Nanoparticle Breath Sensor for Tumor Grading

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for breast cancer diagnosis, such as mammography, MRI, and ultrasound, are inadequate for young women and those undergoing treatment, and breath analysis techniques face challenges in distinguishing between benign and malignant tumors with high sensitivity and specificity.

Innovation Solution

A method using a sensor array comprising conductive nanoparticles capped with organic coatings and a pattern recognition algorithm to analyze volatile organic compounds (VOCs) in exhaled breath, allowing for the differentiation between benign and malignant tumors by measuring multiple response-induced parameters.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If mammography is used for breast cancer screening, then early diagnosis capability is improved, but radiation exposure risk increases

Engineering Contradiction:
Improveearly diagnosis capabilityVSAvoidradiation exposure risk
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent replaces the mechanical/radiation-based mammography system with a chemical sensing system using nanoparticle sensors that detect volatile organic compounds in breath. This substitution eliminates radiation exposure while maintaining diagnostic capability through detection of cancer-specific VOC signatures.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces breath analysis as an intermediary method between direct breast imaging and cancer diagnosis. Instead of directly imaging the breast with radiation, the system analyzes VOCs in breath that are produced by cancer metabolism, providing indirect but radiation-free detection.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If ultrasound imaging is used for tumor detection, then non-invasive detection is improved, but tumor identification accuracy deteriorates

Engineering Contradiction:
Improvenon-invasive detectionVSAvoidtumor identification accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent changes the detection parameter from physical/structural properties (ultrasound waves reflecting off tumor structures) to chemical properties (VOC composition in breath). This parameter change enables both non-invasive operation and high accuracy by detecting cancer-specific chemical signatures rather than relying on structural imaging.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If MRI is used for breast tumor detection, then sensitivity to tumors is improved, but specificity deteriorates leading to false positives

Engineering Contradiction:
Improvesensitivity to tumorsVSAvoidspecificity to breast tumors
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent segments the detection approach by using multiple nanoparticle sensors with different organic coatings, each sensitive to different VOCs. This segmentation allows the system to detect specific patterns of multiple VOCs simultaneously, enabling differentiation between cancer types and reduction of false positives through pattern recognition rather than single-marker detection.

Inventive Principle:
Principle #1Segmentation

4Device complexity

If a single sensor is used for VOC detection, then device complexity is reduced, but measurement precision deteriorates

Engineering Contradiction:
Improvesensor array complexityVSAvoidtumor differentiation accuracy
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The patent divides the detection system into multiple sensor elements, each with specific organic coatings that bind to different VOCs. This segmentation of the sensing function enables detection of multiple VOCs simultaneously, providing sufficient measurement precision for tumor differentiation while keeping each individual sensor relatively simple.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent combines multiple sensor responses into a unified pattern recognition analysis. By merging the data from multiple sensors detecting different VOCs, the system achieves high measurement precision for tumor differentiation, using the combined information to distinguish between benign and malignant tumors with high accuracy.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach provides improved sensitivity and selectivity for diagnosing, monitoring, and staging breast cancer, enabling the distinction between benign and malignant tumors and their grades, overcoming limitations of existing techniques.

Implementation Method 1

measuring a response from said at least one sensor upon exposure to said test sample

Methodology Applied
Scientific EffectConductivity change upon VOC exposure: Conduction (electrical)

Implementation Method 2

Gas-sensing devices for the detection of VOCs in breath samples have recently been applied

Methodology Applied
Scientific EffectAdsorption of VOCs on nanoparticle surface: Adsorption

Data Source

PatentUS9678059B2Detection, staging and grading of benign and malignant tumors
Publication Date: 2017.06.13 TECHNION RES & DEV FOUND LTD
  • US9678059B2 patent drawing
  • US9678059B2 patent drawing
  • US9678059B2 patent drawing

AI summary

The present invention provides a method for detecting and grading benign and malignant tumors using at least one sensor of conductive nanoparticles capped with an organic coating in conjunction with a learning and pattern recognition algorithm. The method utilizes a plurality of response induced parameters to obtain improved sensitivity and selectivity for diagnosis, prognosis, monitoring and staging various types of cancers, or for identifying or grading benign or malignant tumors.